First PH-made train to operate this May

Robie de Guzman   •   April 24, 2019   •   3876

MANILA, Philippines — The country’s first domestically-made hybrid electric train will soon start operations, the Department of Science and Technology (DOST) announced on Wednesday.

In a Facebook post, the DOST Philippine Council for Industry, Energy and Emerging Technology Research and Development (PCIEERD) said the first locally-made electric train will begin commercial operations on May 6. Its passengers will get to ride the new train for free for more than two weeks.

“FYI: Starting May 6, passengers will have the chance to ride the Hybrid Electric Train (HET) for free for 19 days,” the DOST PCIEERD said.

The agency, which developed the train, said the Philippine National Railways (PNR) will operate the train on the Alabang-Biñan route.

The train set will be turned over to PNR after completing the 150-hour test which will simulate actual commercial use.

“The Philippine National Railways will have to complete 150 hours (approx. 19 days) run time for the train which will run the Alabang-Biñan route as part of its turn over process,” it said.

https://facebook.com/dostpcieerd/posts/1472317199572025

The train was designed and built by DOST engineers and local fabricators.

It runs on technology similar to Toyota Prius hybrid cars and has a maximum capacity of 880 passengers.

It is expected to run from 50 to 80 kilometers per hour (kph), faster than current PNR train speed at 40kph.

Train coaches are fully airconditioned and equipped with CCTV system, LED TV sets and automatic sliding doors.

The agency earlier said that maintaining the Filipino-made hybrid electric train will be easier and much cheaper unlike other railway systems in Metro Manila because its spare parts are available locally.

READ: PH to operate first locally-made commuter train soon

This innovation provides a huge potential in tapping local engineers and fabricators and the necessary boost for the country’s mass transport system. — Robie de Guzman

IATF approves Phl participation in COVID-19 vaccine clinical trials

Maris Federez   •   May 24, 2020

MANILA, Philippines — Upon the recommendation of the Department of Science and Technology (DOST), the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-MEID) has approved the proposed participation of the Philippines in clinical trials that seek to formulate a potential vaccine against coronavirus disease 2019 (COVID-19).

Based on IATF Resolution No.39 dated May 22, 2020, the task force has also ordered the creation of a sub-technical working group which will be led by the DOST.

The group will be coordinating with the four collaborating organizations composed of the Department of Health (DOH), the Food and Drug Administration (FDA), the Research Institute for Tropical Medicine (RITM), and the World Health Organization (WHO) with regard to the said clinical trials.

The IATF has also issued a directive to the FDA to facilitate the processing of necessary permits for the conduct of the clinical trials in the country.

The collaborating organizations for the clinical trials are the Adimmune Corporation, Academia Sinica, Chinese Academy of Science- Guangzhou Institute of Biomedicine and Health, the Sinopharm – Wuhan Institute of Biological Products, and the Beijing Institute.

Once the clinical trials are undertaken, these will be included in the FDA’s requirements for the registration process for the vaccine and the application for certificate of registration to make the vaccine available in the market.

The Philippines has initially participated in the WHO’s clinical trials, which include the testing of off-label drugs that show potential of being effective against COVID-19.

Meanwhile, the IATF has also approved the plans of the DOST to construct research centers for the local vaccine research development.

These include the Virology S&T Institute at the New Clark City in Tarlac and the reactivation of the Pharmaceutical Development Unit of the DOST-Industrial Technology Development Institute. —(from the report of Rosalie Coz) /mbmf

Duterte approves hiring of additional workers for FDA, DOST

Marje Pelayo   •   April 28, 2020

MANILA, Philippines — The Food and Drug Administration (FDA) is busy processing applications for licenses of coronavirus disease (COVID-19) test kits and all other products necessary in the country’s fight against the global pandemic.

The Department of Science and Technology (DOST), meanwhile, is focusing on research and development of treatment or vaccine against COVID-19.

Due to the volume of work and the high demand for additional workforce, President Rodrigo Duterte has allowed the two agencies to hire more personnel to join the government’s COVID-19 response.

“I have authorized these two offices — the FDA and the DOST — to employ as much as many that would be required to expedite [the processes] and to enable the agencies to work day and night. As I have said, we are fighting a war here, a crisis,” the President said in Filipino during his live address to the nation on Monday (April 27).

Meanwhile in his Joint Congressional Oversight Committee report, the President noted that the Department of Budget and Management (DBM) already approved the hiring of additional workers for the Department of Health (DOH). 

The DOH requested for additional 15,757 healthcare professionals who will be given three-months contract of service and will be funded with P2.7-billion.

The DOH said seven hospitals have signified their request for additional medical personnel to cope with the volume of workload in relation to the COVID-19 pandemic. MNP (with reports from Rosalie Coz)

DOST eyes collaborations with other countries to develop COVID-19 vaccine

Marje Pelayo   •   April 27, 2020

MANILA, Philippines — The Department of Science and Technology (DOST) is willing to accept individuals or organizations who wish to collaborate with the government in developing a cure against coronavirus disease (COVID-19).

The idea comes after President Rodrigo Duterte’s offer of P50 million cash reward to anyone who will develop the much needed vaccine.

But according to DOST Secretary Fortunato dela Peña, the task will not be easy as there is no established institution in the country dedicated to the development of vaccines.

Developing a vaccine is a tedious and lengthy process but the official said many institutions focusing on research and development (R&D) may attempt to develop one for COVID-19.

“Mayroon silang biorepository ng iba’t-ibang samples so puwede. Madali silang maka-shift into a particular disease lalo na kung may history na sila na naka-develop na sila ng mga vaccines,” Dela Peña said.

(They have biorepository of different samples so it’s possible. It is easier for them to shift [focus] into a particular disease especially if they already have a history of developing vaccines.)

Aside from seeking interests from here in the Philippines, the Department eyes working in partnership with other countries with bilateral agreement with the Philippines on R&D and are currently conducting studies and experiments on a potential vaccine for COVID-19.

Kung nandoon na sila sa stage na mayroon na silang na-develop ay makikisabay tayo sa kanila sa clinical trials,” the DOST chief said.

(If they are in that stage of developing [a vaccine], we will just collaborate with their clinical trials.)

Meanwhile, the DOST is sending samples of locally-produced lauric acid to other countries for testing if such can directly fight viruses such as the one causing COVID-19.

Lauric acid is a by-product of coconut fat which is believed to have potential benefits to human health. – MNP (with inputs from Rey Pelayo)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.